Barriers and facilitators to provide multidisciplinary care for breast cancer patients in five Latin American countries: A descriptive-interpretative qualitative study
Carlos Barrios, Guillermo Sánchez-Vanegas, Cynthia Villarreal-Garza, Andrés Ossa, Milton A Lombana, Angélica Monterrosa-Blanco, Ana S Ferrigno, Carlos Alberto Castro DOI: 10.1016/j.lana.2022.100254 Full link: https://pubmed.ncbi.nlm.nih.gov/36778924/
Implications of the PEARL trial from the low- to middle-income countries’ perspectives
Tomás Reinert, Aline C Gonçalves, C A A de Resende, Carlos H Barrios DOI: DOI: 10.1016/j.ejca.2022.06.016 Full link: https://linkinghub.elsevier.com/retrieve/pii/S0959804922003677
Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study
Andre G Gouveia, Fabio Y Moraes, Renato P Lima, Gustavo A Viani DOI: 10.5603/RPOR.a2022.0070 Full link: https://journals.viamedica.pl/rpor/article/view/90772
Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study
Andre G Gouveia, Fabio Y Moraes, Renato P Lima, Gustavo A Viani DOI: 10.5603/RPOR.a2022.0070 Full link: https://journals.viamedica.pl/rpor/article/view/90772
Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil
Marcelo Langer Wroclawski, Breno Santos Amaral, Paulo Priante Kayano, Wilson Francisco Schreiner Busato Jr, Sebastião José Westphal, Erik Montagna, Bianca Bianco, Andrey Soares, Fernando Cotait Maluf, Gustavo Caserta Lemos, Arie Carneiro DOI: 10.1186/s12894-022-01036-1 Full link: https://bmcurol.biomedcentral.com/articles/10.1186/s12894-022-01036-1
Non–Small-Cell Lung Cancer With CNS Metastasis: Disparities From a Real-World Analysis (GBOT-LACOG 0417)
Juliano Cé Coelho, Giselle de Souza Carvalho, Fabio Chaves, Pedro de Marchi, Gilberto de Castro Jr, Clarissa Baldotto, Eldsamira Mascarenhas, Patricia Pacheco, Rafaela Gomes, Gustavo Werutsky and Luiz H. Araujo. DOI: https://doi.org/10.1200/GO.21.00333 Full link: https://ascopubs.org/doi/full/10.1200/GO.21.00333
Drug Development in Low- and Middle-Income Countries: Opportunity or Exploitation?
Rakesh Jalali 1, Angelica Nogueira-Rodrigues 2, Arunangshu Das 3, Bhawna Sirohi 4, Pankaj Kumar Panda 5 DOI: 10.1200/EDBK_10033 Full link: https://ascopubs.org/doi/10.1200/EDBK_10033
A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)
Fernando Sabino M Monteiro, Andrey Soares, Vinicius Carrera Souza, Rubens Copia Sperandio, Enrique Grande, Matteo Santoni, Andre Poisl Fay, Andre Deeke Sasse DOI: 10.1016/j.clgc.2022.04.008 Full link: https://linkinghub.elsevier.com/retrieve/pii/S1558767322000854
Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: A cohort study with meta-analysis
Gustavo Arruda Viani, Andre Guimaraes Gouveia, Elton Trigo Teixeira Leite, Fabio Ynoe Moraes DOI: 10.1016/j.radonc.2022.03.006 Full link: https://pubmed.ncbi.nlm.nih.gov/35288228/
Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
Marion T van Mackelenbergh, Fenja Seither, Volker Möbus, Joyce O'Shaughnessy, Miguel Martin, Heikki Joensuu, Michael Untch, Ulrike Nitz, Guenther G Steger, Juan J Miralles, Carlos H Barrios, Masakazu Toi, Harry D Bear, Hyman Muss, Toralf Reimer, Valentina Nekljudova, Sibylle Loibl DOI: 10.1016/j.ejca.2022.02.003 Full link: https://www.ejcancer.com/article/S0959-8049(22)00076-4/fulltext